US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.877
- +0.002+0.25%
Trading Nov 19 11:28 ET
36.62MMarket Cap-574P/E (TTM)
0.895High0.865Low44.67KVolume0.890Open0.875Pre Close39.23KTurnover0.20%Turnover RatioLossP/E (Static)41.75MShares3.16052wk High-3.30P/B19.75MFloat Cap0.80052wk Low--Dividend TTM22.51MShs Float51.357Historical High--Div YieldTTM3.41%Amplitude0.800Historical Low0.878Avg Price1Lot Size
About Carisma Therapeutics Company
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Company Profile
SymbolCARM
Company NameCarisma Therapeutics
Listing DateFeb 6, 2014
Founded2016
CEOMr. Steven Kelly
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address3675 Market Street,Suite 200
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Websitehttp://carismatx.com
Company Executives
- Name
- Position
- Salary
- Steven Kelly
- Director, President and Chief Executive Officer
- 3.50M
- Richard S. Morris, C.P.A.
- Chief Financial Officer
- 1.66M
- Dr. Michael Klichinsky, PhD,Pharm.D.
- Chief Scientific Officer
- 1.60M
- Sanford S. Zweifach
- Chairman of the Board
- 271.55K
- Marella Thorell
- Director
- --
- Dr. David T. Scadden, M.D.
- Director
- --
- Sohanya Cheng
- Director
- --
- Dr. Briggs W. Morrison, M.D.
- Independent Director
- 220.20K
- Dr. John A. Hohneker, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data